CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax has been constructed and a preliminary study was done on its cellular immunogenicity to recipient BALB/c mice. The PvAMA-1 gene was cloned and expressed in the plasmid vector UBpcAMA-1, and a protein band of approximately 56.8 kDa was obtained from the transfected COS7 cells. BALB/c mice were immunized intramuscularly or using a gene gun 4 times with the vaccine, and the proportions of splenic T-cell subsets were examined by fluorocytometry at week 2 after the last injection. The spleen cells from intramuscularly injected mice revealed no significant changes in the proportions of CD8+ T-cells and CD4+ T-cells. However, in mice immunized using a gene gun, significantly higher (P<0.05) proportions of CD8+ cells were observed compared to UB vector-injected control mice. The results indicated that cellular immunogenicity of the plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax was weak when it was injected intramuscularly; however, a promising effect was observed using the gene gun injection technique.
Abstract
Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax has been constructed and a preliminary study was done on its cellular immunogenicity to recipient BALB/c mice. The PvAMA-1 gene was cloned and expressed in the plasmid vector UBpcAMA-1, and a protein band of approximately 56.8 kDa was obtained from the transfected COS7 cells. BALB/c mice were immunized intramuscularly or using a gene gun 4 times with the vaccine, and the proportions of splenic T-cell subsets were examined by fluorocytometry at week 2 after the last injection. The spleen cells from intramuscularly injected mice revealed no significant changes in the proportions of CD8+ T-cells and CD4+ T-cells. However, in mice immunized using a gene gun, significantly higher (P<0.05) proportions of CD8+ cells were observed compared to UB vector-injected control mice. The results indicated that cellular immunogenicity of the plasmid DNA vaccine encoding AMA-1 of the reemerging Korean P. vivax was weak when it was injected intramuscularly; however, a promising effect was observed using the gene gun injection technique.
참고문헌 (25)
- Gurunathan S, "DNA vaccines: Immunology, application, and optimization", Annu Rev Immunol, 18, pp.927~979 (2000)
- "Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A", J mice, 2003, pp.21, 1432~1444
- Rogers WO, "Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens", Vaccine, 17(3136), pp.3136~3144 (1999)
- Dobaño C, "Plasmodium: Mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity", Exp Parasitol, 122, pp.112~123 (2009)
- Remarque EJ, "Apical membrane antigen 1: A malaria vaccine candidate in review", Trends Parasitol, 24, pp.74~84 (2008)
- Kusi KA, "Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity", PLOS One, 4, pp.8110~ (2009)
- Dutta S, "High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model", PLOS One, 4, pp.8138~ (2009)
- Kocken CHM, "High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: Strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2", Infect Immun, 67, pp.43~49 (1999)
- Bueno LL, "Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells", Vaccine, 27, pp.5581~5588 (2009)
- Herrera S, "An update on the search for a Plasmodium vivax vaccine", Trends Parasitol, 23, pp.122~128 (2007)
- "Update on development of vaccines against Plasmodium vivax malaria" (2005)[URL]
- Rodriguez MHC, "Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1", Int J Parasitol, 35, pp.185~192 (2005)
- Zhang M, "A novel DNA vaccine based on ubiquitin-proteasome pathway targeting ‘self’-antigens expressed in melanoma", melanocyte, 2005, pp.12, 1049~1057
- Chai JY, "trial for a DNA diagnosis of Plasmodium vivax malaria recently reemerging in the Republic of Korea using microtiter plate hybridization assay", Am J Trop Med Hyg, 63(1), pp.80~84 (2000)
- Eun-TaekHAN, "Apical membrane antigen-1 (AMA-1) gene sequences of re-emerging Plasmodium vivax in South Korea", The Korean Journal of Parasitology, 40(3), pp.157~162 (2002), 대한기생충학회
- Chung JY, "Analysis of the Plasmodium vivax apical membrane antigen-1 gene from re-emerging Korean isolates", Parasitol Res, 90, pp.325~329 (2003)
- Han ET, "Allelic dimorphism in the merozoite surface protein-3 alpha in Korean isolates of Plasmodium vivax", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 71(745), pp.745~749 (2004), AMER SOC TROP MED & HYGIENE
- Pizarro JC, "Crystal structure of the malaria vaccine candidate apical membrane antigen 1", Science, 308, pp.408~411 (2005)
- Lin K, "Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar", ACTA TROPICA, 114(2), pp.71~75 (2010), ELSEVIER SCIENCE BV
- Putaporntip C, "Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand", Infect Genet Evol, 9, pp.1295~1300 (2009)
- Kloetzel PM, "Antigen processing by the proteasome", Nat Rev Mol Cell Bio, 2, pp.179~187 (2001)
- Narum DL, "Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice", Infect Immun, 69, pp.7250~7253 (2001)
- Yazdani SS, "Chitnis CE. Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimization", Biotechnol Lett, 28, pp.1109~1114 (2006)
- Yoshida A, "Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses", Vaccine, 18, pp.1725~1729 (2000)
- Wang S, "The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods", Vaccine, 26, pp.2100~2110 (2008)